1 |
Yao Q, Zhang X, Chen D. Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases. Front Oncol 2022;12:848296. [DOI: 10.3389/fonc.2022.848296] [Reference Citation Analysis]
|
2 |
Zeng C, Yuan G, Hu Y, Wang D, Shi X, Zhu D, Hu A, Meng Y, Lu J. Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma. Bioengineered 2022;13:1491-506. [PMID: 34986757 DOI: 10.1080/21655979.2021.2020549] [Reference Citation Analysis]
|
3 |
Mafra D, Alvarenga L, Cardozo LF, Stockler-pinto MB, Nakao LS, Stenvinkel P, Shiels PG. Inhibiting BTB domain and CNC homolog 1 (Bach1) as an alternative to increase Nrf2 activation in chronic diseases. Biochimica et Biophysica Acta (BBA) - General Subjects 2022. [DOI: 10.1016/j.bbagen.2022.130129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Yu Y, Zuo W, Cai W, Xu Y, Liu W, Zhao Z. MiR-129-5p Suppresses Cell Proliferation of Human Osteosarcoma Cancer by Down-Regulating LncRNA Lnc712. Cancer Manag Res 2021;13:2259-64. [PMID: 33732018 DOI: 10.2147/CMAR.S284078] [Reference Citation Analysis]
|